The Melanoma Research Alliance has announced funding for 28 research grants totaling $11.8 million.
The awards will fund researchers at 23 institutions from across the United States, Australia, and Belgium to accelerate research and advance the prevention, diagnosis and treatment of melanoma.
This year’s grant awards will support 13 Team Science Awards and 15 Young Investigator Awards. Together, these awards represent the single largest grant year ever by the Melanoma Research Alliance and brings the total invested by the organization to over $100 million.
These 28 research projects will accelerate research addressing critical issues in melanoma, including identifying novel drug targets, treatments and biomarkers, as well as studies aimed at preventing melanoma or improving methods of early detection.
Several research projects will provide critical advancements in the understanding of rare and difficult-to-treat melanoma subtypes. Six awards will examine new therapeutic interventions to determine how specific genetic alterations contribute to the development and progression to acral lentiginous melanoma.
MRA’s 2018 grants are made possible through the significant contributions of individuals, families, institutions and corporate allies. Donors and partners providing financial support for 75% or more of an award are listed below within the award naming.
